Search Results 1411-1420 of 17349 for Hormone Transition
Men with breast cancer: Your experience wth hormonal therapy? 24 ... Hormone therapy for breast cancer · Lumpectomy · Mammogram · Mastectomy · Molecular ...
ᵃ Hormonal methods not prone to drug-drug interactions. Non-sterilised male partners of a woman of childbearing potential must use a male condom plus ...
Elucidating a Rare Pituitary Cancer · Pituitary Tumors: Patient-Centered Care Facilitates Strong Outcomes · Mayo Clinic Clinical Trials in Patients With Tumor- ...
Primary Care — Pharmacist collaboration during care transitions adds measurable value. Joel Streed. December 17, 2020. Science Saturday: Mayo study shows gene ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Cho D, Weingarten TN, Sprung J, Zodl A, Ryll MJ, Harrison TE. Dantrolene use across surgical and medical care at Mayo Clinic from 2010 to 2024: Indications, ...
Active, known, or suspected serious autoimmune disease, except for type I diabetes mellitus, hypothyroidism only requiring hormone replacement, skin ...
Enzalutamide is not FDA approved to treat salivary gland cancer, but it has already been FDA-approved to treat other cancers. Participation eligibility.
About this study. The purpose of this study evaluates a subset of people with isolated Impaired Fasting Glucose with Normal Glucose Tolerance (i.e., ...
About this study. The overall goal of this investigator-initiated trial is to evaluate the impact of platform algorithm products designed to rapidly ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.